| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZYNE | Zynerba Pharmaceuticals, Inc. | Fickenscher James E | Chief Financial Officer | Sep 13, 2023 | Sale | $1.33 | 8,998 | 11,929 | 378,087 | Sep 14, 2023, 04:13 PM | |
| ZYNE | Zynerba Pharmaceuticals, Inc. | Fickenscher James E | Chief Financial Officer | Feb 08, 2023 | Option Exercise | $0.60 | 6,544 | 3,903 | 355,885 | Feb 09, 2023, 05:11 PM | |
| ZYNE | Zynerba Pharmaceuticals, Inc. | Fickenscher James E | Chief Financial Officer | Feb 01, 2023 | Option Exercise | $0.60 | 5,927 | 3,528 | 339,882 | Feb 02, 2023, 08:08 PM | |
| ZYNE | Zynerba Pharmaceuticals, Inc. | Fickenscher James E | Chief Financial Officer | Jan 23, 2023 | Sale | $0.60 | 17,769 | 10,622 | 154,736 | Jan 25, 2023, 05:28 PM | |
| ZYNE | Zynerba Pharmaceuticals, Inc. | Fickenscher James E | Chief Financial Officer | Jul 19, 2022 | Sale | $1.10 | 6,013 | 6,614 | 172,505 | Jul 20, 2022, 04:05 PM | |
| ZYNE | Zynerba Pharmaceuticals, Inc. | Fickenscher James E | Chief Financial Officer | Aug 06, 2018 | Buy | $5.97 | 8,518 | 50,842 | 20,718 | Aug 07, 2018, 04:28 PM | |
| ZYNE | Zynerba Pharmaceuticals, Inc. | Fickenscher James E | Chief Financial Officer | May 12, 2017 | Buy | $19.82 | 5,200 | 103,064 | 12,200 | May 16, 2017, 08:50 AM | |
| ZYNE | Zynerba Pharmaceuticals, Inc. | Fickenscher James E | Chief Financial Officer | Dec 06, 2016 | Buy | $14.15 | 3,000 | 42,450 | 3,000 | Dec 08, 2016, 02:01 PM | |
| ZYNE | Zynerba Pharmaceuticals, Inc. | Fickenscher James E | Chief Financial Officer | Dec 07, 2016 | Buy | $14.03 | 4,000 | 56,120 | 7,000 | Dec 08, 2016, 02:01 PM | |
| ATRS | ANTARES PHARMA, INC. | Fickenscher James E | Senior Vice President & CFO | Jun 02, 2016 | Option Exercise | $1.12 | 121,050 | 135,576 | 391,266 | Jun 06, 2016, 05:19 PM | |
| ATRS | ANTARES PHARMA, INC. | Fickenscher James E | Senior Vice President & CFO | Mar 18, 2016 | Buy | $0.72 | 135,000 | 97,200 | 270,216 | Mar 21, 2016, 09:13 AM | |
| ATRS | ANTARES PHARMA, INC. | Fickenscher James E | Senior Vice President & CFO | Dec 11, 2014 | Buy | $2.49 | 40,000 | 99,800 | 40,000 | Dec 15, 2014, 05:49 PM | |
| AUXL | AUXILIUM PHARMACEUTICALS INC | Fickenscher James E | Chief Financial Officer | Jun 21, 2014 | Option Exercise | $21.18 | 80 | 1,694 | 68,603 | Jun 23, 2014, 04:33 PM | |
| AUXL | AUXILIUM PHARMACEUTICALS INC | Fickenscher James E | Chief Financial Officer | Feb 18, 2014 | Option Exercise | $28.30 | 668 | 18,904 | 48,683 | Feb 20, 2014, 05:34 PM | |
| AUXL | AUXILIUM PHARMACEUTICALS INC | Fickenscher James E | Chief Financial Officer | Feb 07, 2014 | Option Exercise | $23.68 | 2,156 | 51,054 | 42,976 | Feb 11, 2014, 09:35 PM | |
| AUXL | AUXILIUM PHARMACEUTICALS INC | Fickenscher James E | Chief Financial Officer | Dec 11, 2013 | Sale | $12.57 | 142,134 | 1,787,150 | 116,199 | Dec 12, 2013, 04:05 PM | |
| AUXL | AUXILIUM PHARMACEUTICALS INC | Fickenscher James E | Chief Financial Officer | Jun 21, 2013 | Option Exercise | $17.15 | 80 | 1,372 | 45,132 | Jun 25, 2013, 04:00 PM | |
| AUXL | AUXILIUM PHARMACEUTICALS INC | Fickenscher James E | Chief Financial Officer | Feb 07, 2013 | Option Exercise | $18.30 | 482 | 8,821 | 45,212 | Feb 11, 2013, 05:26 PM | |
| AUXL | AUXILIUM PHARMACEUTICALS INC | Fickenscher James E | Chief Financial Officer | Feb 28, 2012 | Option Exercise | $20.07 | 1,053 | 21,134 | 25,786 | Mar 01, 2012, 05:00 PM | |
| AUXL | AUXILIUM PHARMACEUTICALS INC | Fickenscher James E | Chief Financial Officer | Nov 03, 2011 | Buy | $15.54 | 1,610 | 25,024 | 26,839 | Nov 07, 2011, 05:05 PM | |
| AUXL | AUXILIUM PHARMACEUTICALS INC | Fickenscher James E | Chief Financial Officer | Feb 28, 2011 | Option Exercise | $22.47 | 941 | 21,144 | 25,247 | Apr 04, 2011, 08:38 PM |
Menu